首页> 外文期刊>Biochemical and Biophysical Research Communications >Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway
【24h】

Androgen receptor regulated microRNA miR-182-5p promotes prostate cancer progression by targeting the ARRDC3/ITGB4 pathway

机译:雄激素受体调节的microRNA miR-182-5p通过靶向ARRDC3 / ITGB4途径促进前列腺癌的进展

获取原文
获取原文并翻译 | 示例
           

摘要

MicroRNAs (miRNAs) are important endogenous gene regulators that play key roles in prostate cancer development and metastasis. However, specific miRNA expression patterns in prostate cancer tissues from Chinese patients remain largely unknown. In this study, we compared miRNA expression patterns in 65 pairs of prostate cancer and para-cancer tissues by RNA sequencing and found that miR-182-5p was the most up-regulated miRNA in prostate cancer tissues. The result was validated using realtime PCR in 18 pairs of prostate cancer and para-cancer tissues. In in vitro analysis, it was confirmed that miR-182-5p promotes prostate cancer cell proliferation, invasion and migration and inhibit apoptosis. In addition, the androgen receptor directly regulated the transcription of miR-182-Sp, which could target to the 3'UTR of ARRDC3 mRNA and affect the expression of ARRDC3 and its downstream gene ITGB4. For the in vivo experiment, miR-182-5p overexpression also promoted the growth and progression of prostate cancer tumors. In this regard, we suggest that miR-182-5p may be a key androgen receptor-regulated factor that contributes to the development and metastasis of Chinese prostate cancers and may be a potential target for the early diagnosis and therapeutic studies of prostate cancer. (C) 2016 Elsevier Inc. All rights reserved.
机译:MicroRNA(miRNA)是重要的内源基因调节剂,在前列腺癌的发展和转移中起关键作用。然而,在中国患者的前列腺癌组织中特定的miRNA表达模式仍然未知。在这项研究中,我们通过RNA测序比较了65对前列腺癌和癌旁组织中的miRNA表达模式,发现miR-182-5p是前列腺癌组织中上调最多的miRNA。使用实时PCR在18对前列腺癌和癌旁组织中验证了该结果。在体外分析中,证实了miR-182-5p促进前列腺癌细胞的增殖,侵袭和迁移并抑制凋亡。此外,雄激素受体直接调节miR-182-Sp的转录,其可能靶向ARRDC3 mRNA的3'UTR,并影响ARRDC3及其下游基因ITGB4的表达。对于体内实验,miR-182-5p过表达还促进了前列腺癌肿瘤的生长和发展。在这方面,我们建议miR-182-5p可能是关键的雄激素受体调节因子,有助于中国前列腺癌​​的发展和转移,并且可能是前列腺癌早期诊断和治疗研究的潜在目标。 (C)2016 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号